S.H. Rosenberg

1.2k total citations
12 papers, 588 citations indexed

About

S.H. Rosenberg is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, S.H. Rosenberg has authored 12 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Oncology. Recurrent topics in S.H. Rosenberg's work include Renin-Angiotensin System Studies (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Microtubule and mitosis dynamics (2 papers). S.H. Rosenberg is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Microtubule and mitosis dynamics (2 papers). S.H. Rosenberg collaborates with scholars based in United States and United Kingdom. S.H. Rosenberg's co-authors include Steven W. Elmore, Laurie Iciek, Morey L. Smith, Paul Nimmer, Ryan M. Fryer, Glenn A. Reinhart, Randy Nelson, Lee C. Preusser, S. J. Morgan and Christin Tse and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Cell Death and Differentiation and Clinical Chemistry.

In The Last Decade

S.H. Rosenberg

11 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.H. Rosenberg United States 8 356 182 140 74 62 12 588
Enrique Poradosu United States 10 308 0.9× 135 0.7× 80 0.6× 38 0.5× 86 1.4× 17 556
Li‐En Shao United States 13 635 1.8× 150 0.8× 70 0.5× 44 0.6× 43 0.7× 21 803
François Wilhelm United States 16 270 0.8× 264 1.5× 220 1.6× 75 1.0× 25 0.4× 64 796
Xiaofen Pan China 15 330 0.9× 107 0.6× 141 1.0× 67 0.9× 102 1.6× 35 706
S. M. LUDEMAN United States 9 380 1.1× 275 1.5× 152 1.1× 137 1.9× 16 0.3× 12 730
Florence Namour Belgium 14 188 0.5× 194 1.1× 99 0.7× 150 2.0× 40 0.6× 29 646
Arthur Groy United States 6 497 1.4× 279 1.5× 48 0.3× 45 0.6× 64 1.0× 7 696
Rodrigo Blake United States 4 183 0.5× 67 0.4× 145 1.0× 38 0.5× 15 0.2× 6 394
James Kalabus United States 13 301 0.8× 296 1.6× 223 1.6× 27 0.4× 15 0.2× 22 661
J. P. Eder United States 10 143 0.4× 148 0.8× 113 0.8× 50 0.7× 23 0.4× 21 418

Countries citing papers authored by S.H. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of S.H. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.H. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.H. Rosenberg more than expected).

Fields of papers citing papers by S.H. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.H. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.H. Rosenberg. The network helps show where S.H. Rosenberg may publish in the future.

Co-authorship network of co-authors of S.H. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of S.H. Rosenberg. A scholar is included among the top collaborators of S.H. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.H. Rosenberg. S.H. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nimmer, Paul, Ryan M. Fryer, Laurie Iciek, et al.. (2007). Bcl-2 family proteins are essential for platelet survival. Cell Death and Differentiation. 14(5). 943–951. 335 indexed citations
2.
Rosenberg, S.H., et al.. (2004). Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study. Cancer Chemotherapy and Pharmacology. 54(3). 273–81. 38 indexed citations
3.
Joseph, Ingrid B.J., David Ferguson, Joann P. Palma, et al.. (2004). 473 Poly(ADP-ribose) polymerase inhibitor, ABT-472 enhances antitumor activity of doxorubicin in human xenograft models and protects against drug-induced cardiac toxicity. European Journal of Cancer Supplements. 2(8). 144–144. 4 indexed citations
4.
Tahir, Sajid Khan, Edward K. Han, Hwan-Soo Jae, et al.. (2001). A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.. PubMed. 61(14). 5480–5. 60 indexed citations
5.
Han, Edward K., Laura Gehrke, Sajid Khan Tahir, et al.. (2000). Modulation of drug resistance by α-tubulin in paclitaxel-resistant human lung cancer cell lines. European Journal of Cancer. 36(12). 1565–1571. 43 indexed citations
6.
Tahir, Sajid Khan, Wen‐Zhen Gu, Juan H. Leal, et al.. (2000). Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue. European Journal of Cancer. 36(9). 1161–1170. 10 indexed citations
7.
Gu, Wen‐Zhen, Sajeev Cherian, Stephen J. O’Connor, et al.. (1999). Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo. European Journal of Cancer. 35(9). 1394–1401. 37 indexed citations
8.
Dayton, Brian D., Herman H. Stein, William R. Baker, et al.. (1992). Effects of Angiotensinase Inhibitors on Plasma Protein Binding and IC50 Determinations of Renin Inhibitors. Clinical Chemistry. 38(11). 2239–2243. 2 indexed citations
9.
Stein, Herman H., S.H. Rosenberg, Keith W. Woods, et al.. (1990). Biochemical and pharmacological properties of ABBOTT-65317, a potent renin inhibitor. European Journal of Pharmacology. 183(4). 1306–1307.
10.
Verburg, Kenneth M., et al.. (1990). Effect of intrarenal renin inhibition on renal hemodynamics and excretory function. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 259(1). R7–R14. 5 indexed citations
11.
Burnier, Miguel N., I. W. McLean, Lorenz E. Zimmerman, & S.H. Rosenberg. (1990). Retinoblastoma. The relationship of proliferating cells to blood vessels.. PubMed. 31(10). 2037–40. 38 indexed citations
12.
Kleinert, Hollis D., D. Martin, G. A. R. Young, et al.. (1988). Cardiovascular actions of the primate-selective renin inhibitor, A-62198.. Journal of Pharmacology and Experimental Therapeutics. 246(3). 975–979. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026